2,064
Views
26
CrossRef citations to date
0
Altmetric
Special Report

The impact of coffee consumption on blood pressure, cardiovascular disease and diabetes mellitus

Pages 151-156 | Received 23 Nov 2016, Accepted 24 Jan 2017, Published online: 03 Feb 2017

References

  • USA NCA. National coffee drinking trends 2012. New York, NY: National Coffee Association USA; 2012.
  • Noordzij M, Uiterwaal CS, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized cotrolled trials. J Clin Hypertens. 2005;23:921–928.
  • D’Avanzo B, la Vecchia C, Tognoni G, et al.; on behalf of GISSI-EFRIM. Coffee consumption and risk of acute myocardial infarction in Italian males. Ann Epidemiol. 1993;3:595–600.
  • Baylin A, Hernandez-Diaz S, Kabbagambe EK, et al. Transient exposure to coffee as a trigger of a first myocardial infarction. Epidemiology. 2006;17:506–511.
  • Wilhemsen L, Rosengren A, Eriksson H, et al. Heart failure in the general population men-morbidity, risk factors and prognosis. J Intern Med. 2001;249:253–261.
  • Dobmeyer DJ, Stine RA, Leier CV, et al. The arrhythmogenic effects of caffeine in human beings. N Engl J Med. 1983;308:814–816.
  • Thong FL, Graham TE. Caffeine-induced impairment of glucose tolerance is abolished by β-adrenergic receptor blockade in humans. J Appl Physiol. 2002;92:2347–2352.
  • Sofi F, Conti AA, Gori AM, et al. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2007;17:209–223.
  • Bhupathiraju SN, Pan A, Manson JE, et al. Changes in coffee intake and subsequent risk of type 2 diabetes: three large cohorts of US men and women. Diabetologia. 2014;57:1346–1354.
  • Zuchinali P, Souza GC, Pimentel M, et al. Short-term effects of high-dose caffeine on cardiac arrhythmias in patients with heart failure. A randomized clinical. JAMA Intern Med. 2016 Oct 17;176:1752.
  • Rebello SA, van Dam RM. Coffee consumption and cardiovascular health: getting to the heart of the matter. Curr Cardiol Rep. 2013;15:403.
  • O’Keefe JH, Bhatti SK, Patil HR, et al. Effects of habitual coffee consumption and cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013;62:1043–1051.
  • Steffen M, Kuhle C, Hensrud D, et al. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:2245–2254.
  • Zhang Z, Hu G, Caballero B, et al. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr. 2011;93:1212–1219.
  • Mesas AE, Leon-Munoz LM, Rodriguez-Artelejo F, et al. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113–1216.
  • Ding M, Bhupathiraju SN, Satija A, et al. Long-term coffee consumption and risk of cardiovascular disease. A systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129:643–659.
  • di Castelnuovo A, Di Giuseppe R, Iacoviello L, et al. Consumption of cocoa, tea, and coffee and risk of cardiovascular disease. Eur J Intern Med. 2012;23:15–25.
  • Malerba S, Turati F, Galeone C, et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28:527–539.
  • Liu J, Sui X, Lavie CJ, et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88:1066–1074.
  • Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891–1904.
  • de Koning Gans JM, Uiterwaal CS, van der Schouw YT, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30:1665–1671.
  • Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140:1007–1013.
  • Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, et al. Coffee consumption and mortality in women with cardiovascular disease. Am J Clin Nutr. 2011;94:218–224.
  • Floegel A, Pischon T, Bergmann MM, et al. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) - Germany study. Am J Clin Nutr. 2012;95:901–908.
  • Kokubo Y, Iso H, Saito I, et al. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population. The Japan public health center-based study cohort. Stroke. 2013;44:1369–1374.
  • Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis. Am J Epidemiol. 2011;174:993–1001.
  • Mostofsky E, Rice MS, Levitan EB, et al. Habitual coffee consumption and risk of heart failure. A dose-response meta-analysis. Circ Heart Fail. 2012;5:401–405.
  • Wang Y, Tuomilehto J, Jousilahti P, et al. Coffee consumption and the risk of heart failure in Finnish men and women. Heart. 2011;97:44–48.
  • Rhee JJ, Qin FF, Hedlin HK, et al. Coffee and caffeine consumption in postmenopausal women. Am J Clin Nutr. 2016;103:210–217.
  • Grosso G, Stepaniak U, Polak M, et al. Coffee consumption and risk of hypertension in the Polish arm of the HAPIEE cohort study. Eur J Clin Nutr. 2016;70:109–115.
  • Zuchinali P, Rbeiro PAB, Pimentel M, et al. Effects of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies. Europace. 2016;18:257–266.
  • Klatsky AL, Hasan AS, Armstrong MA, et al. Coffee, caffeine, and risk of hospitalization for arrhythmias. Permanente J. 2011;15:19–25.
  • Larsson SC, Drca N, Jensen-Urstad M, et al. Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and meta-analysis. BMC Med. 2015;13:207.
  • Conen D, Chiuve SE, Everett BM, et al. Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr. 2010;92:509–514.
  • Caldeira D, Martins C, Brandao Alves L, et al. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart. 2013;99:1383–1389.
  • Cheng M, Hu Z, Lu X, et al. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol. 2014;30:448–454.
  • Mattioli AV, Farinetti A, Miloro C, et al. Influence of coffee and caffeine consumption on atrial fibrillation in hypertensive patients. Nutr Metab Cardiovasc Dis. 2011;21:412–417.
  • van Dam RB, Mansom JE, Willett TT, et al. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006;29:398–403.
  • Ding M, Bhupathiraju SN, Chen M, et al. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2014;37:569–586.
  • McCarty MF. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Medical Hypotheses. 2005;64:848–853.
  • Bohn SK, Ward NC, Hodgson JM, et al. Effects of tea and coffee on cardiovascular disease risk. Food Funct. 2012;3:575–591.
  • Guessous I, Eap CB, Bohud M. Blood pressure in relation to coffee and caffeine consumption. Curr Hypertens Rep. 2014;16:468.
  • Guessous I, Pruijm M, Ponte B, et al. Association of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretions. Hypertension. 2015;65:691–696.
  • Chrysant SG, Chrysant GS. Cardiovascular complications from consumption of high energy drinks: recent evidence. J Hum Hypertens. 2015;29:71–76.
  • Modlinger PS, Welch WJ. Adenosine A1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens. 2003;12:497–502.
  • Gottlieb SS, Brater DC, Thomas I, et al. BG 9719 (CVT-124) an adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;105:1348–1353.
  • Zhao Y, Wang J, Ballevre O, et al. Antihypertensive effects and mechanisms of chlorogenic acids. J Hum Hypertens. 2012;35:370–374.
  • Cano-Marquina A, Tarin JJ, Cano A. The impact of coffee on health. Maturitas. 2013;75:7–21.
  • Papamichael CM, Aznaouridis KA, Karatzis EN, et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci. 2005;109:55–60.
  • Busceni S, Verga S, Batsis JA, et al. Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr. 2009;63:1200–1205.
  • Reis JP, Loria CM, Steffen LM, et al. Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: the CARDIA study. Atheroscler Thromb Vasc Biol. 2010;30:2059–2066.
  • Renda G, Zimarino M, Antonucci I, et al. Genetic determinants of blood pressure responses to caffeine drinking. Am J Clin Nutr. 2012;95:241–248.
  • Perera V, Gross AS, Mclachlan AJ. Influence of environmental and genetic factors of CYP1A2 activity in individuals of South Asian and European ancestry. Clin Pharmacol Ther. 2012;92:511–519.
  • Palatini P, Ceoloto G, Ragazzo F, et al. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens. 2009;27:1594–1601.
  • Lopez-Garcia E, Orozco-Arbelaez E, Leon-Munoz LM, et al. Habitual coffee consumption and 24-h blood pressure control in older adults with hypertension. Clin Nutr. 2016;35:1457–1463.
  • Guessous I, Dobrinas M, Kutalik Z, et al. Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Hum Mol Genet. 2012;21:3283–3292.
  • Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009;169:2053–2063.
  • Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997;17:305–324.
  • Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153:353–362.
  • Glatter KA, Myers R, Chiamvimonvat N. Recommendations regarding dietary intake and caffeine and alcohol consumption in patients with cardiac arrhythmias: what do you tell your to do or not to do. Curr Treat Options Cardiovasc Med. 2012;14:529–535.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.